Changeflow GovPing Pharma & Drug Safety Sulforaphane Supplement in Gummy Form Patent Ap...
Routine Notice Added Draft

Sulforaphane Supplement in Gummy Form Patent Application

Favicon for changeflow.com ChangeBridge: Patent Apps - Pharma (A61K)
Published September 26th, 2025
Detected March 26th, 2026
Email

Summary

The USPTO has published a patent application (US20260083667A1) for a sulforaphane supplement in gummy form. The application, filed by Sensory Scout LLC, describes a composition including sulforaphane, glucoraphanin, and myrosinase immobilized within a gummy matrix. This represents a new patent filing for a novel supplement formulation.

What changed

The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083667A1, filed on September 26, 2025. The application, assigned to Sensory Scout LLC, details a sulforaphane supplement formulated in a gummy form. The core innovation lies in the composition, which includes sulforaphane, glucoraphanin, and myrosinase, with these active ingredients disposed and immobilized within the gummy matrix structure.

This publication signifies a new patent application for a specific dietary supplement formulation. While patent applications do not impose direct regulatory obligations on other entities, they indicate potential future product development and market entry in the supplement and pharmaceutical sectors. Companies involved in the development or manufacturing of dietary supplements, particularly those containing sulforaphane or similar compounds, should be aware of this filing as it may relate to intellectual property landscapes and competitive offerings in the market.

Source document (simplified)

← USPTO Patent Applications

SULFORAPHANE SUPPLEMENT IN GUMMY FORM

Application US20260083667A1 Kind: A1 Mar 26, 2026

Assignee

Sensory Scout LLC

Inventors

Benzion Sadigursky

Abstract

A sulforaphane supplement in gummy form, including an active ingredient composition comprising sulforaphane, glucoraphanin, and myrosinase. The supplement including a matrix structure in which sulforaphane, glucoraphanin, and myrosinase are disposed in pores and immobilized therein.

CPC Classifications

A61K 9/0056 A61K 31/26 A61K 31/7028 A61K 36/31 A61K 38/47 A61K 47/12 A61K 47/26 A61K 47/36 C12Y 302/01147

Filing Date

2025-09-26

Application No.

19341677

View original document →

Classification

Agency
USPTO
Published
September 26th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083667A1

Who this affects

Applies to
Drug manufacturers Food manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Dietary Supplement Manufacturing Pharmaceutical Research
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Product Development Dietary Supplements

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.